Terms: = Endocrine gland cancer AND PPARG, PPARG1, 5468, ENSG00000132170, PPARG2, NR1C3, HUMPPARG
85 results:
1. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
2. Integrated bioinformatics and network pharmacology to explore the therapeutic target and molecular mechanisms of Bailing capsule on polycystic ovary syndrome.
Guan HR; Li B; Zhang ZH; Wu HS; He XL; Dong YJ; Su J; Lv GY; Chen SH
BMC Complement Med Ther; 2023 Dec; 23(1):458. PubMed ID: 38102584
[TBL] [Abstract] [Full Text] [Related]
3. Exosome and lipid metabolism-related genes in pancreatic adenocarcinoma: a prognosis analysis.
Wu J; Li Y; Nabi G; Huang X; Zhang X; Wang Y; Huang L
Aging (Albany NY); 2023 Oct; 15(20):11331-11368. PubMed ID: 37857015
[TBL] [Abstract] [Full Text] [Related]
4. Detection of driver mutations in plasma cell-free nucleic acids in differentiated thyroid neoplasm.
Dutta S; Tarafdar S; Mukhopadhyay P; Bhattacharyya NP; Ghosh S
Eur J Endocrinol; 2023 Jan; 188(1):. PubMed ID: 36744987
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological significance of major fusion oncogenes in papillary thyroid carcinoma: An individual patient data meta-analysis.
Vuong HG; Le HT; Le TTB; Le T; Hassell L; Kakudo K
Pathol Res Pract; 2022 Dec; 240():154180. PubMed ID: 36306725
[TBL] [Abstract] [Full Text] [Related]
6. Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Clamp AR; James EC; McNeish IA; Dean A; Kim JW; O'Donnell DM; Gallardo-Rincon D; Blagden S; Brenton J; Perren TJ; Sundar S; Lord R; Dark G; Hall M; Banerjee S; Glasspool RM; Hanna CL; Williams S; Scatchard KM; Nam H; Essapen S; Parkinson C; McAvan L; Swart AM; Popoola B; Schiavone F; Badrock J; Fananapazir F; Cook AD; Parmar M; Kaplan R; Ledermann JA
Lancet Oncol; 2022 Jul; 23(7):919-930. PubMed ID: 35690073
[TBL] [Abstract] [Full Text] [Related]
7. Relationship of
Asya O; Yumuşakhuylu AC; Bağcı P; Kaya H; Gönen A; Gündoğdu Y; Muradov T; Şahin A; Oysu Ç
Acta Otorhinolaryngol Ital; 2022 Feb; 42(1):34-40. PubMed ID: 35292786
[TBL] [Abstract] [Full Text] [Related]
8. Testing of mutations on thyroid nodules with indeterminate cytology: A prospective study of 112 patients in Argentina.
Tolaba N; Spedalletti Y; Bazzoni P; Galindez M; Cerioni V; Santillan C; Richter G; Herrera C; Sanchez L; Van Cawulaert L; Toscano MA; Nallar M; Monteros Alvi M; Moya CM
Endocrinol Diabetes Nutr (Engl Ed); 2022 Feb; 69(2):122-130. PubMed ID: 35256055
[TBL] [Abstract] [Full Text] [Related]
9. High Prevalence of DICER1 Mutations and Low Frequency of Gene Fusions in Pediatric Follicular-Patterned Tumors of the Thyroid.
Bae JS; Jung SH; Hirokawa M; Bychkov A; Miyauchi A; Lee S; Chung YJ; Jung CK
Endocr Pathol; 2021 Sep; 32(3):336-346. PubMed ID: 34313965
[TBL] [Abstract] [Full Text] [Related]
10. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
Pan Y; Wu L; He S; Wu J; Wang T; Zang H
Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
[TBL] [Abstract] [Full Text] [Related]
11.
Aier I; Semwal R; Sharma A; Varadwaj PK
J Biomol Struct Dyn; 2021 Aug; 39(13):4893-4901. PubMed ID: 32579088
[TBL] [Abstract] [Full Text] [Related]
12. miRNA expression can classify pediatric thyroid lesions and increases the diagnostic yield of mutation testing.
Franco AT; Labourier E; Ablordeppey KK; Surrey LF; Mostoufi-Moab S; Isaza A; Adzick NS; Kazahaya K; Kumar G; Bauer AJ
Pediatr Blood Cancer; 2020 Jun; 67(6):e28276. PubMed ID: 32196952
[TBL] [Abstract] [Full Text] [Related]
13. A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Gomes-Lima CJ; Auh S; Thakur S; Zemskova M; Cochran C; Merkel R; Filie AC; Raffeld M; Patel SB; Xi L; Wartofsky L; Burman KD; Klubo-Gwiezdzinska J
Front Endocrinol (Lausanne); 2020; 11():53. PubMed ID: 32132976
[No Abstract] [Full Text] [Related]
14. Evaluation of BRAF, RAS, RET/PTC, and PAX8/pparg alterations in different Bethesda diagnostic categories: A multicentric prospective study on the validity of the 7-gene panel test in 1172 thyroid FNAs deriving from different hospitals in South Italy.
Bellevicine C; Migliatico I; Sgariglia R; Nacchio M; Vigliar E; Pisapia P; Iaccarino A; Bruzzese D; Fonderico F; Salvatore D; Biondi B; Masone S; Novizio V; Scavuzzo F; Serino D; De Palma M; Chiofalo MG; Botti G; Pezzullo L; Nuzzo V; Spiezia S; De Chiara G; Iorio S; Conzo G; Docimo G; Faggiano A; Bongiovanni M; Malapelle U; Colao A; Triassi M; Troncone G;
Cancer Cytopathol; 2020 Feb; 128(2):107-118. PubMed ID: 31821746
[TBL] [Abstract] [Full Text] [Related]
15. Hobnail cells in encapsulated papillary thyroid carcinoma: Report of 2 cases with immunohistochemical and molecular findings and literature analysis.
Agarwal S; Sadiq Q; Ortanca I
Pathol Res Pract; 2020 Mar; 216(3):152678. PubMed ID: 31740230
[TBL] [Abstract] [Full Text] [Related]
16. Macrofollicular Variant of Follicular Thyroid Carcinoma: A Rare Underappreciated Pitfall in the Diagnosis of Thyroid Carcinoma.
Bongiovanni M; Sykiotis GP; La Rosa S; Bisig B; Trimech M; Missiaglia E; Gremaud M; Salvatori Chappuis V; De Vito C; Sciarra A; Foulkes WD; Pusztaszeri M
Thyroid; 2020 Jan; 30(1):72-80. PubMed ID: 31701808
[No Abstract] [Full Text] [Related]
17. PANCREATICODUODENECTOMY WITH VENOUS RESECTION: AN ANALYSIS OF 30-DAY MORBIDITY AND MORTALITY.
Callejas GH; Concon MM; Rezende AQM; Chaim EA; Callejas-Neto F; Cazzo E
Arq Gastroenterol; 2019; 56(3):246-251. PubMed ID: 31633719
[TBL] [Abstract] [Full Text] [Related]
18. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
19. Oncogenic KRAS Reduces Expression of FGF21 in Acinar Cells to Promote Pancreatic Tumorigenesis in Mice on a High-Fat Diet.
Luo Y; Yang Y; Liu M; Wang D; Wang F; Bi Y; Ji J; Li S; Liu Y; Chen R; Huang H; Wang X; Swidnicka-Siergiejko AK; Janowitz T; Beyaz S; Wang G; Xu S; Bialkowska AB; Luo CK; Pin CL; Liang G; Lu X; Wu M; Shroyer KR; Wolff RA; Plunkett W; Ji B; Li Z; Li E; Li X; Yang VW; Logsdon CD; Abbruzzese JL; Lu W
Gastroenterology; 2019 Nov; 157(5):1413-1428.e11. PubMed ID: 31352001
[TBL] [Abstract] [Full Text] [Related]
20. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
Zhou J; Hui X; Mao Y; Fan L
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
[TBL] [Abstract] [Full Text] [Related]
[Next]
